Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
filingDate |
2001-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f57d33843b06d7858a1798347f43cd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97cf5231090a2c56a0058d77e9fa9dd6 |
publicationDate |
2002-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002132247-A1 |
titleOfInvention |
Dystrophia myotonica protein kinase (DM-PK) and its uses |
abstract |
Detection of DM-PK expression in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. DM-PK further provides a target for screening pharmaceutical agents effective in inhibiting the growth or metastasis of tumor cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006023211-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006023211-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010009923-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318670-B2 |
priorityDate |
2000-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |